Jenny Kobin | executive |
George Lasezkay | executive |
Charlie Deignan | executive |
Annabel Samimy | analyst |
Greetings, and welcome to the Clearside Biomedical Q4 2023 Financial Results and Corporate Update Call. [Operator Instructions] Please note, this conference is being recorded.
I will now turn the conference over to your host, Jenny Kobin, of Clearside Investor Relations. Jenny, you may begin.
Good afternoon, everyone, and thank you for joining us on the call today.